CKD Bio Corp
063160
Company Profile
Business description
CKD Bio Corp is engaged in producing high-quality raw pharmaceutical ingredients, such as antibiotics and immunosuppressants, and supply them to domestic and international pharmaceutical companies. The company also purchases finished pharmaceutical products from domestic and international markets for export and domestic supply.
Contact
8 Chungjeong-ro, 3-ga Chungjeong-ro
Seodaemun-gu
Seoul
KORT: +82 221940555
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
530
Stocks News & Analysis
stocks
Coca-Cola earnings: Innovation and brand strength underpin growth
We plan to raise our fair value estimate of Coca-Cola stock.
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,321.10 | 10.80 | -0.12% |
| CAC 40 | 8,232.54 | 26.32 | -0.32% |
| DAX 40 | 24,262.49 | 67.54 | -0.28% |
| Dow JONES (US) | 46,858.28 | 66.46 | -0.14% |
| FTSE 100 | 9,523.86 | 96.87 | 1.03% |
| HKSE | 25,781.77 | 245.78 | -0.94% |
| NASDAQ | 22,927.02 | 26.65 | -0.12% |
| Nikkei 225 | 49,307.79 | 8.27 | -0.02% |
| NZX 50 Index | 13,306.44 | 71.41 | -0.53% |
| S&P 500 | 6,736.00 | 0.65 | 0.01% |
| S&P/ASX 200 | 9,030.00 | 10.30 | -0.11% |
| SSE Composite Index | 3,913.76 | 2.57 | -0.07% |